HHS and Kaiser Family Foundation leverage phone texting technology to help people locate their nearest HIV/AIDS testing facility. Although slow to be adopted by the pharma industry, text marketing is becoming a useful tool to send health information directly to patients.
To take advantage of the nearly 18.5 billion text messages being sent every month, the Department of Health and Human Services (HHS) and the Kaiser Family Foundation have established a text messaging service that informs people of the location of the nearest HIV testing center.
The campaign launched on World AIDS Day, December 1. To find a testing location, users simply type their zip code into the phone and send it to the number 566948, or KNOWIT. The number connects to the Center for Disease Control and Prevention's HIV testing database and returns a message with a list of nearby sites.
"In the last couple of years, we have used text messaging because it is one of the fastest-growing media technologies, and it is very popular with young people," Jennifer Kates, VP and director of HIV policy at the Kaiser Family Foundation, told Pharm Exec. "Texting is also very common for African Americans and is used more than the Internet."
HHS and the CDC approached the Foundation to learn how to use Kaiser's existing text-messaging platform as part of a combined World AIDS Day campaign. The text message information is promoted across all the partners' Web sites, brochures, and posters.
"With HIV prevention, you really need to reach people where they are, in the multiple ways, so that they get information," Kates said. "We also have to be quick, because young people are at the forefront of new technology."
Text PHARMA
Although text messaging has yet to be adopted as a marketing strategy by most pharma companies, the technology has been implemented in a number of health information and compliance campaigns.
"One of the challenges with pharma is all the regulations around marketing," Mike Jelley, cofounder of electronic-marketing firm Ipsh!, told Pharm Exec on Tuesday. "Any time you design a program that is sponsored by a pharma company, there are a lot of pitfalls and a lot of concerns from a legal and compliance standpoint. However, there is a lot of potential in areas of awareness."
Some pharma companies are using text messaging to increase dosing compliance. They are sending patients text messages with reminders to take their medication.
"This not only helps the patient complete a dosage, but it is also good for the pharma companies because they sell more products," Jelley said. "These types of campaigns are less restrictive from a regulatory standpoint because the company isn't pushing a particular drug. However, there are less measurable results."
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Pfizer, GSK Gain ACIP Recommendations for RSV and Meningococcal Vaccines
April 18th 2025The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand access to Pfizer’s respiratory syncytial virus vaccine Abrysvo for high-risk adults in their 50s and voted in favor of GSK’s meningococcal vaccine, Penmenvy, for streamlined adolescent protection.